Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293842753> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4293842753 endingPage "6" @default.
- W4293842753 startingPage "1" @default.
- W4293842753 abstract "Objectives: The present investigation is concerned with formulation and evaluation of mucoadhesive buccal tablets containing antidiabetic drug, glimepiride, to circumvent the first pass effect and to improve its bioavailability with reduction in dosing frequency and dose related side effects. Methods: The tablets were prepared by direct compression method. The tablets were tested for weight variation, hardness, surface pH, drug content uniformity, percentage swelling index, bio adhesive strength, exvivo residence time in-vitro drug dissolution study, in-vitro drug release kinetic study, ex-vivo permeation study and stability study. Results: FTIR studies showed no evidence on interactions between drug, polymers, and excipients. The surface pH, bio adhesive strength, ex-vivo residence timeand swelling index of formulation was found to be 6.80±0.02, 36.3±0.04g, 325min and 289.8±0.52%, respectively. The formulation containing 4 mg of glimepiride exhibited 6 h sustained drug release i.e. 93.98±0.8% with desired therapeutic concentration. The drug permeation from the formulation was slow and steady and 3.56 mg of glimepiride could permeate through sheep buccal membrane with a flux of 0.27 mg hr-1 cm-2 . The in-vitro release kinetics studies reveal that all formulations fits well with zero order kinetics and followed non-Fickian diffusion mechanism. Conclusion: Hence, it was concluded that the best formulation was suitable for all the evaluation parameters and can be permeated through human buccal mucosa." @default.
- W4293842753 created "2022-08-31" @default.
- W4293842753 creator A5010572250 @default.
- W4293842753 creator A5010902459 @default.
- W4293842753 creator A5044488896 @default.
- W4293842753 date "2019-07-31" @default.
- W4293842753 modified "2023-10-07" @default.
- W4293842753 title "Preparation of glimepiride mucoadhesive tablets by direct compression method and their in-vitro evaluation" @default.
- W4293842753 doi "https://doi.org/10.56770/jcp2019311" @default.
- W4293842753 hasPublicationYear "2019" @default.
- W4293842753 type Work @default.
- W4293842753 citedByCount "0" @default.
- W4293842753 crossrefType "journal-article" @default.
- W4293842753 hasAuthorship W4293842753A5010572250 @default.
- W4293842753 hasAuthorship W4293842753A5010902459 @default.
- W4293842753 hasAuthorship W4293842753A5044488896 @default.
- W4293842753 hasBestOaLocation W42938427531 @default.
- W4293842753 hasConcept C134018914 @default.
- W4293842753 hasConcept C14029885 @default.
- W4293842753 hasConcept C159985019 @default.
- W4293842753 hasConcept C178790620 @default.
- W4293842753 hasConcept C181389837 @default.
- W4293842753 hasConcept C185592680 @default.
- W4293842753 hasConcept C191168616 @default.
- W4293842753 hasConcept C192562407 @default.
- W4293842753 hasConcept C195735259 @default.
- W4293842753 hasConcept C201253974 @default.
- W4293842753 hasConcept C202751555 @default.
- W4293842753 hasConcept C26291073 @default.
- W4293842753 hasConcept C2776035855 @default.
- W4293842753 hasConcept C2776307423 @default.
- W4293842753 hasConcept C2777180221 @default.
- W4293842753 hasConcept C2778540859 @default.
- W4293842753 hasConcept C41625074 @default.
- W4293842753 hasConcept C43617362 @default.
- W4293842753 hasConcept C50670333 @default.
- W4293842753 hasConcept C521977710 @default.
- W4293842753 hasConcept C55493867 @default.
- W4293842753 hasConcept C555293320 @default.
- W4293842753 hasConcept C71924100 @default.
- W4293842753 hasConcept C98274493 @default.
- W4293842753 hasConceptScore W4293842753C134018914 @default.
- W4293842753 hasConceptScore W4293842753C14029885 @default.
- W4293842753 hasConceptScore W4293842753C159985019 @default.
- W4293842753 hasConceptScore W4293842753C178790620 @default.
- W4293842753 hasConceptScore W4293842753C181389837 @default.
- W4293842753 hasConceptScore W4293842753C185592680 @default.
- W4293842753 hasConceptScore W4293842753C191168616 @default.
- W4293842753 hasConceptScore W4293842753C192562407 @default.
- W4293842753 hasConceptScore W4293842753C195735259 @default.
- W4293842753 hasConceptScore W4293842753C201253974 @default.
- W4293842753 hasConceptScore W4293842753C202751555 @default.
- W4293842753 hasConceptScore W4293842753C26291073 @default.
- W4293842753 hasConceptScore W4293842753C2776035855 @default.
- W4293842753 hasConceptScore W4293842753C2776307423 @default.
- W4293842753 hasConceptScore W4293842753C2777180221 @default.
- W4293842753 hasConceptScore W4293842753C2778540859 @default.
- W4293842753 hasConceptScore W4293842753C41625074 @default.
- W4293842753 hasConceptScore W4293842753C43617362 @default.
- W4293842753 hasConceptScore W4293842753C50670333 @default.
- W4293842753 hasConceptScore W4293842753C521977710 @default.
- W4293842753 hasConceptScore W4293842753C55493867 @default.
- W4293842753 hasConceptScore W4293842753C555293320 @default.
- W4293842753 hasConceptScore W4293842753C71924100 @default.
- W4293842753 hasConceptScore W4293842753C98274493 @default.
- W4293842753 hasIssue "1" @default.
- W4293842753 hasLocation W42938427531 @default.
- W4293842753 hasOpenAccess W4293842753 @default.
- W4293842753 hasPrimaryLocation W42938427531 @default.
- W4293842753 hasRelatedWork W2887840362 @default.
- W4293842753 hasRelatedWork W3079367330 @default.
- W4293842753 hasRelatedWork W3131155625 @default.
- W4293842753 hasRelatedWork W4293842753 @default.
- W4293842753 hasRelatedWork W4328051879 @default.
- W4293842753 hasRelatedWork W1574491038 @default.
- W4293842753 hasRelatedWork W2183360752 @default.
- W4293842753 hasRelatedWork W2183887755 @default.
- W4293842753 hasRelatedWork W2185894170 @default.
- W4293842753 hasRelatedWork W2188059200 @default.
- W4293842753 hasVolume "3" @default.
- W4293842753 isParatext "false" @default.
- W4293842753 isRetracted "false" @default.
- W4293842753 workType "article" @default.